Development of immune radiotherapy with yttrium by targeting Frizzled homologue 10 (FZD10) in cervical cancer
FZD10 may be an appropriate target and <sup>90</sup>Y-OTSA101 may have potential for the treatment of cervical cancer.
Authors
- Yuki Okuma
- Shinobu Masuda (ORCID: https://orcid.org/0000-0002-0361-8071)
- Keisuke Saito (ORCID: https://orcid.org/0000-0002-2293-9743)
- Saki Kamata
- Kei Kawana (ORCID: https://orcid.org/0000-0003-1919-8830)
- Takahiro Nakajima (ORCID: https://orcid.org/0000-0001-5576-4153)
- Osamu Kobayashi (ORCID: https://orcid.org/0000-0001-7517-5495)
- Erina Matsuda
- Yosuke Harada (ORCID: https://orcid.org/0000-0001-9827-4963)
- Jae‐Hyun Park
- Yuji Ikeda (ORCID: https://orcid.org/0000-0002-0036-2365)
- Yusuke Nakamura (ORCID: https://orcid.org/0000-0003-2956-382X)
- Yoko Nakanishi
- Naoko Tomita
- Suyoun Chung
Institutions
- Nihon University (JP)
- National Institute of Biomedical Innovation, Health and Nutrition (JP)
- OncoTherapy Science (Japan) (JP)
Publication Details
- Journal
- Gynecologic Oncology Reports
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1016/j.gore.2025.101736
- Citations
- 1
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.06
Funders
- Japan Society for the Promotion of Science